Bioengineered yeast could revolutionize avian flu vaccines with shelf-stable protection. Discover how this innovative ...

Novavax, Inc. (NASDAQ:NVAX) on Thursday revealed preclinical data from the H5N1 avian pandemic influenza vaccine candidate. Leveraging Novavax’s recombinant, protein-based nanoparticle technology and ...

The United States Deptartment of Agriculture recently awarded scientists at Binghamton University $2.5 million to develop a next-generation avian flu vaccine. The grant is part of an overall $100 ...

BUFFALO, N.Y. — A vaccine under development at the University at Buffalo has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work, detailed in ...

Finland was the first country to offer the zoonotic avian influenza A(H5N8) vaccine manufactured by Seqirus to at-risk occupational groups following the extensive clade 2.3.4.4b A(H5N1) outbreak ...

In a phase I trial, an intranasal adjuvanted recombinant influenza vaccine appeared to result in response to a range of H5N1 clades. The adjuvanted vaccine elicited seroconversion against clade 2 ...

Since it was first detected in the United States in 2014, H5N1 avian influenza, commonly known as bird flu, has jumped from wild birds to farm animals and then to people, causing more than 70 human ...

Are seasonal flu antibodies also effective against avian flu? A team from the University of Geneva (UNIGE) has shown that a specific type of antibody associated with the former virus - already present ...

The rapid spread of H5N1 from wild birds to mammals, and even humans, is raising the stakes in the fight against avian influenza. As experts warn of the virus’s pandemic potential, global action on ...

Are seasonal flu antibodies also effective against avian flu? A team from the University of Geneva (UNIGE) has shown that a specific type of antibody associated with the former virus—already present ...